Is Talaris Therapeutics Inc (TALS) a Leader in the Biotechnology Industry?

Thursday, October 12, 2023 11:11 AM | InvestorsObserver Analysts

Mentioned in this article

Is Talaris Therapeutics Inc (TALS) a Leader in the Biotechnology Industry?

A rating of 61 puts Talaris Therapeutics Inc (TALS) near the middle of the Biotechnology industry according to InvestorsObserver. Talaris Therapeutics Inc's score of 61 means it scores higher than 61% of stocks in the industry. Talaris Therapeutics Inc also received an overall rating of 47, putting it above 47% of all stocks. Biotechnology is ranked 70 out of the 148 industries.

TALS has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on TALS!

See Full TALS Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 47 would rank higher than 47 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Talaris Therapeutics Inc Stock Today?

Talaris Therapeutics Inc (TALS) stock has risen 2.68% while the S&P 500 is lower by -0.04% as of 10:58 AM on Thursday, Oct 12. TALS is up $0.07 from the previous closing price of $2.62 on volume of 29,342 shares. Over the past year the S&P 500 has gained 22.31% while TALS is up 14.96%. TALS lost -$1.79 per share the over the last 12 months. Click Here to get the full Stock Report for Talaris Therapeutics Inc stock.